Hemochron®

Rapid whole blood hemostasis diagnosis and monitoring in acute settings: The Hemochron® Signature Elite system uses a simple, single-use, cartridge-based technology to measure fibrin clot formation. It standardizes high and low heparin ranges (ACT+, ACT-LR) as well as PT and APTT testing at the point of care. Accurate and reproducible results for critical patient-management decisions.

Broad test menu

ACT+ measures heparin effects (1.0-6.0 u/mL blood).
ACT-LR, sensitive to low heparin doses (0.0-2.5 u/mL blood), is the only low-range POC assay indicated for use during extracorporeal life support (ECLS), percutaneous coronary intervention (PCI), vascular procedures, neurointerventional procedures, dialysis.
PT/Citrate PT report INR with an effective INR range of 0.8-10.0, as well as whole blood seconds and plasma equivalent seconds.
APTT and Citrate APTT report whole blood seconds and plasma equivalent seconds on samples containing heparin levels of up to 1.5 U/ml.

Connectivity and compliance

automatic internal electronic Quality Control (QC) with QC lockout, including cartridge and QC expiration, operator tracking and lockout
direct connection to Ethernet and major information systems
POCT-1A compliant

Fields of application

cardiovascular operating rooms
cardiac catheterization labs
interventional neuroradiology suites
emergency departments
ICU
anticoagulation clinics

Related products